On the public citation graph
An Intriguing Purview on the Design of Macrocyclic Inhibitors for Unexplored Protein Kinases through Their Binding Site Comparison
0 signed · 58 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/cmdc.200600199openalex-snapshot
Macrocyclic Aminopyrimidines as Multitarget CDK and VEGF‐R Inhibitors with Potent Antiproliferative Activities
inferredcites →https://doi.org/10.1002/jbm4.10230openalex-snapshot
Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva‐Derived Endothelial Cells
inferredcites →https://doi.org/10.1007/s00044-019-02424-3openalex-snapshot
Macrocyclic effect on inhibitory activity: a modeling study on MerTK inhibitors
inferredcites →https://doi.org/10.1016/j.bmcl.2007.11.074openalex-snapshot
Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities
inferredcites →https://doi.org/10.1016/j.bmcl.2016.10.092openalex-snapshot
Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency
inferredcites →https://doi.org/10.1016/j.bmcl.2022.128874openalex-snapshot
Design, synthesis, and bioactivity evaluation of macrocyclic benzo[b]pyrido[4,3-e][1,4]oxazine derivatives as novel Pim-1 kinase inhibitors
inferredcites →https://doi.org/10.1016/j.csbj.2022.12.014openalex-snapshot
TWN-RENCOD: A novel method for protein binding site comparison
inferredcites →https://doi.org/10.1016/j.ejmech.2022.114894openalex-snapshot
Discovery of novel imidazole chemotypes as isoform-selective JNK3 inhibitors for the treatment of Alzheimer's disease
inferredcites →https://doi.org/10.1016/j.phrs.2021.105463openalex-snapshot
Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update
inferredcites →https://doi.org/10.1021/acs.chemrev.5b00056openalex-snapshot
Macrocyclization Reactions: The Importance of Conformational, Configurational, and Template-Induced Preorganization
inferredcites →https://doi.org/10.1021/acs.chemrev.8b00744openalex-snapshot
Multicomponent Reaction Toolbox for Peptide Macrocyclization and Stapling
inferredcites →https://doi.org/10.1021/acs.chemrev.9b00063openalex-snapshot
Comprehensive Structure–Activity Relationship Studies of Macrocyclic Natural Products Enabled by Their Total Syntheses
inferredcites →https://doi.org/10.1021/acs.jcim.7b00221openalex-snapshot
Conformation Generation: The State of the Art
inferredcites →https://doi.org/10.1021/acs.jctc.7b00885openalex-snapshot
Accurate and Reliable Prediction of the Binding Affinities of Macrocycles to Their Protein Targets
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c00217openalex-snapshot
Synthetic Opportunities and Challenges for Macrocyclic Kinase Inhibitors
inferredcites →https://doi.org/10.1021/acs.jmedchem.2c00173openalex-snapshot
Illuminating the Dark: Highly Selective Inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1,5- a ]pyrimidine-Based Macrocycles
inferredcites →https://doi.org/10.1021/acs.jmedchem.2c00981openalex-snapshot
Discovery of D6808, a Highly Selective and Potent Macrocyclic c-Met Inhibitor for Gastric Cancer Harboring MET Gene Alteration Treatment
inferredcites →https://doi.org/10.1021/acs.jmedchem.3c00393openalex-snapshot
Carbamate JNK3 Inhibitors Show Promise as Effective Treatments for Alzheimer’s Disease: In Vivo Studies on Mouse Models
inferredcites →https://doi.org/10.1021/acs.jmedchem.9b01169openalex-snapshot
Start Selective and Rigidify: The Discovery Path toward a Next Generation of EGFR Tyrosine Kinase Inhibitors
inferredcites →https://doi.org/10.1021/acs.jmedchem.9b01206openalex-snapshot
Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 Inhibitors
inferredcites →https://doi.org/10.1021/acsmedchemlett.5b00403openalex-snapshot
Discovery and Optimization of Macrocyclic Quinoxaline-pyrrolo-dihydropiperidinones as Potent Pim-1/2 Kinase Inhibitors
inferredcites →https://doi.org/10.1021/ci800324mopenalex-snapshot
Identifying and Characterizing Binding Sites and Assessing Druggability
inferredcites →https://doi.org/10.1021/jm00002a019openalex-snapshot
Synthesis and Structure-Activity Relationships of Phenylenebis(methylene)-Linked Bis-Tetraazamacrocycles That Inhibit HIV Replication. Effects of Macrocyclic Ring Size and Substituents on the Aromatic Linker
inferredcites →https://doi.org/10.1021/jm061247vopenalex-snapshot
Structure-Based Design, Synthesis, and Biological Evaluation of Potent and Selective Macrocyclic Checkpoint Kinase 1 Inhibitors
inferredcites →https://doi.org/10.1021/jm1012374openalex-snapshot
Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery
inferredcites →https://doi.org/10.1021/jm400887jopenalex-snapshot
Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?
inferredcites →https://doi.org/10.1021/jm500261qopenalex-snapshot
Discovery of (10 R )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- 2H -8,4-(metheno)pyrazolo[4,3- h ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical…
inferredcites →https://doi.org/10.1021/ml100142yopenalex-snapshot
Thermodynamic and Structural Effects of Macrocyclic Constraints in Protein−Ligand Interactions
inferredcites →https://doi.org/10.1038/nrd2590openalex-snapshot
The exploration of macrocycles for drug discovery — an underexploited structural class
inferredcites →https://doi.org/10.1038/s41573-021-00252-yopenalex-snapshot
Trends in kinase drug discovery: targets, indications and inhibitor design
inferredcites →https://doi.org/10.1074/jbc.m116.771485openalex-snapshot
The Axl kinase domain in complex with a macrocyclic inhibitor offers first structural insights into an active TAM receptor kinase
inferredcites →https://doi.org/10.1080/14656566.2020.1774552openalex-snapshot
Pharmacological and clinical properties of lorlatinib in the treatment of ALK-rearranged advanced non-small cell lung cancer
inferredcites →https://doi.org/10.1111/j.1747-0285.2007.00483.xopenalex-snapshot
New Method for Fast and Accurate Binding‐site Identification and Analysis
inferredcites →https://doi.org/10.1186/s12859-018-2109-2openalex-snapshot
Comparative assessment of strategies to identify similar ligand-binding pockets in proteins
inferredcites →https://doi.org/10.1371/journal.pcbi.1006483openalex-snapshot
A benchmark driven guide to binding site comparison: An exhaustive evaluation using tailor-made data sets (ProSPECCTs)
inferredcites →https://doi.org/10.2174/156802605775009748openalex-snapshot
The Application of Olefin Metathesis to the Synthesis of Biologically Active Macrocyclic Agents
inferredcites →https://doi.org/10.3390/antiox9090859openalex-snapshot
Macrocycles and Supramolecules as Antioxidants: Excellent Scaffolds for Development of Potential Therapeutic Agents
inferredcites →https://doi.org/10.3390/cells9102190openalex-snapshot
JNK3 as Therapeutic Target and Biomarker in Neurodegenerative and Neurodevelopmental Brain Diseases
inferredcites →https://doi.org/10.3390/molecules18066230openalex-snapshot
Macrocyclic Drugs and Synthetic Methodologies toward Macrocycles
inferredcites →https://doi.org/10.3390/molecules27031012openalex-snapshot
Recent Advances in Macrocyclic Drugs and Microwave-Assisted and/or Solid-Supported Synthesis of Macrocycles
inferredcites →https://doi.org/10.3390/molecules27092837openalex-snapshot
An Insight into the Medicinal Chemistry Perspective of Macrocyclic Derivatives with Antitumor Activity: A Systematic Review
inferredcites →https://doi.org/10.3390/ph16071009openalex-snapshot
An Intriguing Purview on the Design of Macrocyclic Inhibitors for Unexplored Protein Kinases through Their Binding Site Comparison
inferredcites →https://doi.org/10.4155/fmc-2021-0342openalex-snapshot
Development of Small Macrocyclic Kinase Inhibitors
inferredcites →https://doi.org/10.4155/fmc.09.115openalex-snapshot
Interview with JüRg Zimmermann, Global Head of Oncology & Exploratory Chemistry at Novartis
inferredcites →https://doi.org/10.4155/fmc.14.3openalex-snapshot
Exploiting Structural Information for Drug-Target Assessment
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1007/978-3-032-18296-8_26openalex-snapshot
Experimental Therapeutic Approaches: Molecular, Genetic, and Behavioral
inferred← citeshttps://doi.org/10.1007/s11912-025-01650-wopenalex-snapshot
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL
inferred← citeshttps://doi.org/10.1016/b978-0-443-23932-8.00005-4openalex-snapshot
Macrocyclization strategy in kinase drug discovery
inferred← citeshttps://doi.org/10.1016/b978-0-443-43974-2.00010-0openalex-snapshot
Small macrocyclic inhibitors of kinase
inferred← citeshttps://doi.org/10.1016/j.apsb.2025.06.002openalex-snapshot
Resistance mutations and the blood–brain barrier: Key challenges in targeted treatment of brain metastatic non-small cell lung cancer
inferred← citeshttps://doi.org/10.1016/j.molstruc.2025.142693openalex-snapshot
Synthesis of novel water-soluble cobalt phthalocyanine decorated with biologically active sodium 2-mercaptoethanesulfonate: Potential anticancer agent
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c02886openalex-snapshot
Macrocycles for Conventionally Druggable Targets: Lessons from Macrocyclic Kinase Inhibitors
inferred← citeshttps://doi.org/10.15212/amm-2024-0070openalex-snapshot
Application of a macrocyclization strategy in kinase inhibitor development
inferred← citeshttps://doi.org/10.3390/ijms25094725openalex-snapshot
Gaining Insights into Key Structural Hotspots within the Allosteric Binding Pockets of Protein Kinases
inferred← citeshttps://doi.org/10.3390/ph16091295openalex-snapshot
An Innovative Approach to Address Neurodegenerative Diseases through Kinase-Targeted Therapies: Potential for Designing Covalent Inhibitors
inferred← citeshttps://doi.org/10.4018/979-8-3373-4627-4.ch009openalex-snapshot
Current Advancement of Enzymatic Targets for the Mitigation of Neurodegenerative Disorders
showing the first 11 of 12 · page through all 12
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.